Cargando…
Uptake of Heterologous or Homologous COVID-19 Booster Dose and Related Adverse Events Among Diabetic Patients: A Multicenter Cross-Sectional Study — China, 2022
WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? Although a third coronavirus disease 2019 (COVID-19) vaccination (booster) dose is highly recommended for diabetic patients, the vaccination behaviors and related adverse events are unclear among diabetic patients with a COVID-19 booster dose. WHAT IS ADDED BY...
Autores principales: | Zhang, Fan, Zhu, Yaxin, He, Zhong, Lan, Xinquan, Song, Moxin, Chen, Xi, Li, Mufan, Yang, Jianzhou, Xu, Junjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902747/ https://www.ncbi.nlm.nih.gov/pubmed/36777467 http://dx.doi.org/10.46234/ccdcw2023.002 |
Ejemplares similares
-
Hesitancy to Receive the Booster Doses of COVID-19 Vaccine Among Cancer Patients in China: A Multicenter Cross-Sectional Survey — Four PLADs, China, 2022
por: Wang, Yuxiao, et al.
Publicado: (2023) -
Immunogenicity and Safety of Homologous Booster Doses of CoronaVac COVID-19 Vaccine in Elderly Individuals Aged 60 Years and Older: A Dosing Interval Study — Yunnan Province, China, 2021–2022
por: Yang, Haitao, et al.
Publicado: (2023) -
Effect of Heart Rate on Major Adverse Cardiovascular Events in Hypertensive Patients with Different Ages and Genders
por: Xi, Yang, et al.
Publicado: (2021) -
Frequency and Nuisance Level of Adverse Events in Individuals Receiving Homologous and Heterologous COVID-19 Booster Vaccine
por: Rzymski, Piotr, et al.
Publicado: (2022) -
Investigation of Adverse Events Experienced by Healthcare Workers following Immunization with Homologous or Heterologous COVID-19 Booster Vaccinations
por: Wei, Yunhua, et al.
Publicado: (2022)